The CeutiCare system can save time and money for Ohio health care systems

• Insurers pay about 66% of patient hospital admissions and EM visits which leaves 33% unreimbursable:
  • Each diabetic patient NOT admitted to the hospital saves $6,000 in unreimbursable cost remaining after insurance pay-out ($18,000 x .33)
  • Each diabetic patient NOT visiting the Emergency Room saves $230 visit ($700 x .33)
    
    
• Annual non-reimbursed treatment costs of a diabetic patient receiving CeutiCare MTM are ~ $930 less
  
  
• With CeutiCare MTM, patients will likely undergo more frequent lab testing
  • Revenue from this additional testing can be expected to be
  • $635 per patient, per year.